Bristol-Myers Squibb
BMY
#169
Rank
S$158.58 B
Marketcap
S$77.87
Share price
0.57%
Change (1 day)
2.89%
Change (1 year)

Revenue for Bristol-Myers Squibb (BMY)

Revenue in 2024: S$65.65 Billion

According to Bristol-Myers Squibb's latest financial reports the company's current revenue (TTM ) is S$60.72 Billion. In 2024 the company made a revenue of S$65.65 Billion an increase over the revenue in the year 2023 that were of S$59.43 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bristol-Myers Squibb from 1996 to 2024

Annual revenue

Year Revenue Change
2024S$65.65 B10.45%
2023S$59.43 B-3.95%
2022S$61.88 B-1.32%
2021S$62.70 B11.48%
2020S$56.24 B59.58%
2019S$35.24 B14.36%
2018S$30.82 B10.92%
2017S$27.78 B-1.17%
2016S$28.11 B20.03%
2015S$23.42 B11.64%
2014S$20.98 B1.07%
2013S$20.75 B-3.66%
2012S$21.54 B-21.68%
2011S$27.51 B9.62%
2010S$25.09 B7.07%
2009S$23.44 B-20.42%
2008S$29.45 B11.96%
2007S$26.30 B-4.22%
2006S$27.46 B-14.1%
2005S$31.97 B11.6%
2004S$28.65 B-19.77%
2003S$35.71 B13.61%
2002S$31.43 B-11.45%
2001S$35.50 B7.41%
2000S$33.05 B2.49%
1999S$32.25 B6.85%
1998S$30.18 B7.21%
1997S$28.15 B33.55%
1996S$21.08 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
S$116.48 B 91.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$71.64 B 17.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$79.37 B 30.71%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$75.39 B 24.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$75.11 B 23.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$45.47 B-25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$60.07 B-1.06%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$12.72 B-79.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$81.20 B 33.73%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$73.48 B 21.01%๐Ÿ‡ฌ๐Ÿ‡ง UK